Expression of concern
Second European evidence-based consensus on the diagnosis and management of ulcerative colitis Part 2: Current management
Paper Information
Record ID:
35124
Author(s):
Journal:
Publication Date:
December 01, 2012
Retraction Date:
January 24, 2022
(3.8 years years ago)
Subjects:
Broad Categories:
Medicine
Medicine
Institutions:
- Department of Medicine 1, Agaplesion Markus Hospital, Wilhelm-Epstein-Str. 4, D-60431 Frankfurt/Main, Germany
- Division of Gastroenterology, Department of Medicine, MtSinai Hospital and University Health Network
- University of Toronto, 600 University Avenue, Toronto, ON, Canada
- M5G 1X5 and University of Leuven, Belgium
Countries:
Article Type:
Publisher:
Oxford Academic
Open Access:
Yes
PubMed ID:
Retraction PubMed ID:
Expression of concern Details
Retraction Reasons:
Nature of Retraction:
Expression of concern
Retraction Notice:
10.1093/ecco-jcc/jjab227Additional Notes:
See also: https://doi.org/10.1093/ecco-jcc/jjab225 Journal was previously published by Elsevier until 2015.
Citations (1561)
1561
Total Citations239
Post-Retraction(15.3%)
1316
Pre-Retraction1
Same DayPost-Retraction Citation Analysis
9
Within 30 days
111
Within 1 year
61
After 2+ years
1218
Days since retraction (latest)
Paper citing Second European evidence-based consensus on the di...
Unknown Authors
Unknown Journal
Published: Unknown
Paper citing Second European evidence-based consensus on the di...
Unknown Authors
Unknown Journal
Published: Unknown
Paper citing Second European evidence-based consensus on the di...
Unknown Authors
Unknown Journal
Published: Unknown
Paper citing Second European evidence-based consensus on the di...
Unknown Authors
Unknown Journal
Published: Unknown
Paper citing Second European evidence-based consensus on the di...
Unknown Authors
Unknown Journal
Published: Unknown
Long-term outcome of ciclosporin and infliximab as rescue therapy in steroid-refractory acute severe ulcerative colitis
Florian Grob, Isabel Häberling, Gottfried Novacek et al. (7 authors)
Inflammatory Intestinal Diseases
Open Access
Published: May 2025
1218 days after retraction
Diagnosing Ulcerative Colitis: Should We Go Beyond the Surface?
Vincenzo Villanacci, Giovanni Maconi, Lucrezia Laschi et al. (4 authors)
Journal of Clinical Medicine
Open Access
Published: May 2025
1216 days after retraction
Granulocyte and Monocyte Adsorptive Apheresis Maintenance Therapy Restored the Loss of Response to Anti‐<scp>TNF</scp>‐Alpha Agents in the Patients With <scp>UC</scp>: A Case Report
Nobuhiro Ueno, Yu Kobayashi, Aki Sakatani et al. (12 authors)
Journal of Clinical Apheresis
Open Access
Published: May 2025
1194 days after retraction
Microbial Patterns in Newly Diagnosed Inflammatory Bowel Disease Revealed by Presence and Transcriptional Activity - Relationship to Diagnosis and Outcome
Simen Vatn, Simen H. Hansen, Tone M Tannæs et al. (17 authors)
Clinical and Experimental Gastroenterology
Open Access
Published: May 2025
1193 days after retraction
The Future of Telehealth‐Based Psychological and Mind–Body Interventions for People With Inflammatory Bowel Disease: A Systematic Review
Kaitlyn Delaney Chappell, Otgonbayar Chinbaatar, Karen J. Goodman et al. (4 authors)
Journal of Digestive Diseases
Open Access
Published: Apr 2025
1172 days after retraction
S3-Leitlinie Klinische Ernährung bei chronisch-entzündlichen Darmerkrankungen
Stephan C. Bischoff, Irina Blumenstein, Susanne In der Smitten et al. (12 authors)
Aktuelle Ernährungsmedizin
Published: Apr 2025
1163 days after retraction
Profiles of neutrophilic intestinal inflammation and endothelial dysfunction in patients with inflammatory bowel disease
I. V. Oleksiienko, I. V. Prolygina, О. L. Lovkina et al. (7 authors)
Reports of Vinnytsia National Medical University
Open Access
Published: Mar 2025
1151 days after retraction
Deneysel Sıçan Kolit Modelinde Alfa Lipoik Asit Tedavisinin SOD ve NLRP3 Seviyesi Üzerine Etkisi
Gülbeyaz Özkan, Derya Demir, İrem Taner et al. (5 authors)
Deleted Journal
Open Access
Published: Mar 2025
1148 days after retraction
A two-transcript classifier model for assessing disease activity in patients with ulcerative colitis: A discovery and validation study
Huipeng Zhang, Nan-Nan Xu, Gang Huang et al. (10 authors)
Digestive and Liver Disease
Published: Mar 2025
1132 days after retraction
Dose Escalation Patterns and Associated Costs of Advanced Therapies for Ulcerative Colitis in France and the United Kingdom: A Retrospective Database Analysis
Tamás Treuer, Melissa Richards, Can Mert et al. (7 authors)
ClinicoEconomics and Outcomes Research
Open Access
Published: Mar 2025
1 citation
1 citation
1132 days after retraction
Identification of subtypes and biomarkers associated with disulfidptosis-related ferroptosis in ulcerative colitis
Yinghao Jiang, Hongyan Meng, Xin Zhang et al. (6 authors)
Hereditas
Open Access
Published: Feb 2025
1125 days after retraction
Epigenetic age acceleration and methylation differences in IgG4-related cholangitis and primary sclerosing cholangitis
Alexandra Noble, R. Motta, Silvia Cabras et al. (9 authors)
Clinical Epigenetics
Open Access
Published: Jan 2025
1088 days after retraction
Medical Management 3: Immunomodulators
Gionata Fiorino, Cristina Milazzo, Ornella Giombini et al. (5 authors)
Unknown Journal
Published: Jan 2025
1073 days after retraction
Potential predictors of efficacy outcomes following tofacitinib dose reduction in patients with ulcerative colitis in stable remission: a post hoc analysis of outcomes from the RIVETING study
Joana Torres, Geert D’Haens, Miguel Regueiro et al. (14 authors)
Therapeutic Advances in Gastroenterology
Open Access
Published: Jan 2025
1073 days after retraction
Association of TMAO levels with indicators of ulcerative colitis activity.
Yelena Laryushina, Nadezhda Samoilova-Bedych, L. Turgunova et al. (5 authors)
PubMed
Published: Jan 2025
1073 days after retraction
Future of Acute Severe Ulcerative Colitis—A Narrative Review
Leshni Pillay, Janakan Selvarajah, B. L. Andrew et al. (6 authors)
Journal of Clinical Medicine
Open Access
Published: Dec 2024
1 citation
1 citation
1059 days after retraction
Predictors of pouch failure and quality of life following ileal pouch‐anal anastomosis for ulcerative colitis: a retrospective multicenter study
Ahmet Rencüzoğulları, Cihangir Akyol, İsmail Hamzaoğlu et al. (10 authors)
ANZ Journal of Surgery
Published: Dec 2024
1047 days after retraction
Corticosteroids combined with infliximab vs. corticosteroids sequential infliximab for acute severe ulcerative colitis with mucosal deficiency: a retrospective study
Xiaolei Liu, Xianmin Xue, Xiaojing Zhu et al. (6 authors)
Frontiers in Medicine
Open Access
Published: Nov 2024
1031 days after retraction
Unleashing the potential of extracellular vesicles for ulcerative colitis and Crohn's disease therapy
George C. Njoku, Cathal Patrick Forkan, Fumie Mitani Soltysik et al. (6 authors)
Bioactive Materials
Published: Nov 2024
1 citation
1 citation
1022 days after retraction
Predictors for colectomy in patients with acute severe ulcerative colitis: a systematic review and meta-analysis
Jieqi Zheng, Zinan Fan, Chao Li et al. (6 authors)
BMJ Open Gastroenterology
Open Access
Published: Nov 2024
1 citation
1 citation
1012 days after retraction
The Impact of Cytomegalovirus Infection on Ulcerative Colitis Relapse: A Multicenter Retrospective Cohort Study
Linmei Xiao, Jingjing Ma, Ruidong Chen et al. (9 authors)
Journal of Inflammation Research
Open Access
Published: Nov 2024
1012 days after retraction
Anti-inflammatory effects of para-quinone methide derivatives on ulcerative colitis
Yue Qiu, Xin Li, Xu Dong Zhang et al. (7 authors)
Frontiers in Pharmacology
Open Access
Published: Oct 2024
1 citation
1 citation
1009 days after retraction
Mannose coated selenium nanoparticles normalize intestinal homeostasis in mice and mitigate colitis by inhibiting NF-κB activation and enhancing glutathione peroxidase expression
Hui Yang, Zhiyao Wang, Lixin Li et al. (13 authors)
Journal of Nanobiotechnology
Open Access
Published: Oct 2024
14 citations
14 citations
990 days after retraction
Transition to Subcutaneous Infliximab vs Vedolizumab in Inflammatory Bowel Disease: A Prospective Multicenter Study
Mariabeatrice Principi, Irene Brescia, Elisa Stasi et al. (8 authors)
Digestive Diseases and Sciences
Published: Sep 2024
1 citation
1 citation
980 days after retraction
İnfliksimab ve biyobenzerlerinin steroide refrakter şiddetli ülseratif kolitte kolektomisiz sağ kalıma etkisinin incelenmesi
Fatih Eren, Mehmet Refik GÖKTUĞ, Selcan Cesur et al. (8 authors)
Akademik Gastroenteroloji Dergisi
Open Access
Published: Sep 2024
975 days after retraction
Subcutaneous infliximab in Crohn’s disease patients with previous immunogenic failure of intravenous infliximab
Julia Husman, Karin Černá, Katja Matthes et al. (13 authors)
International Journal of Colorectal Disease
Open Access
Published: Sep 2024
3 citations
3 citations
975 days after retraction
Association of Race and Postoperative Outcomes in Patients with Inflammatory Bowel Disease
John J. Newland, Margaret H. Sundel, Kyle W Blackburn et al. (6 authors)
Digestive Diseases and Sciences
Published: Sep 2024
1 citation
1 citation
961 days after retraction
Global, regional, and national burden of inflammatory bowel disease, 1990–2021: Insights from the global burden of disease 2021
Daopo Lin, Jin Yang, Xiaoxiao Shao et al. (9 authors)
International Journal of Colorectal Disease
Open Access
Published: Sep 2024
27 citations
27 citations
957 days after retraction
Clinical Trial: A Pragmatic Randomised Controlled Study to Assess the Effectiveness of Two Patient Management Strategies in Mild to Moderate Ulcerative Colitis—The OPTIMISE Study
Silvio Danese, Gionata Fiorino, Éric Vicaut et al. (20 authors)
Journal of Clinical Medicine
Open Access
Published: Aug 2024
3 citations
3 citations
949 days after retraction
Enhanced Risk of Gastroesophageal Reflux Disease and Esophageal Complications in the Ulcerative Colitis Population
Xiaoliang Wang, Omar Almetwali, Jiayan Wang et al. (8 authors)
Journal of Clinical Medicine
Open Access
Published: Aug 2024
933 days after retraction
Insights into Probiotic Prescription among Gastroenterologists and Other Healthcare Professionals: Evidence from an Italian Survey
Giovanni Marasco, Angelo Bruni, Olga Maria Nardone et al. (4 authors)
Journal of Clinical Medicine
Open Access
Published: Aug 2024
932 days after retraction
Management of ulcerative colitis in Taiwan: consensus guideline of the Taiwan Society of Inflammatory Bowel Disease updated in 2023
Hsu‐Heng Yen, Jia‐Feng Wu, Horng‐Yuan Wang et al. (30 authors)
Intestinal Research
Open Access
Published: Jul 2024
9 citations
9 citations
918 days after retraction
Non-destructive diagnosis of Inflammatory Bowel Disease by near-infrared spectroscopy and aquaphotomics
Saba Behdad, Reza Massudi, A. Pakdel
Scientific Reports
Open Access
Published: Jul 2024
4 citations
4 citations
898 days after retraction
Real-life effectiveness and safety of vedolizumab in moderate-to-severe ulcerative colitis: A single-center experience in Northern China
Jing Yan, Xueli Ding, Jun Wu et al. (6 authors)
Medicine
Open Access
Published: Jul 2024
3 citations
3 citations
893 days after retraction
Burden of Bowel Urgency in Patients with Ulcerative Colitis and Crohn’s Disease: A Real-World Global Study
Raja Atreya, Isabel Redondo, Petra Streit et al. (10 authors)
Crohn s & Colitis 360
Open Access
Published: Jul 2024
2 citations
2 citations
889 days after retraction
Comparison of early <i>versus</i> late addition of granulocyte and monocyte adsorption for incomplete remission induction in ulcerative colitis
Keiichi Tominaga, Mimari Kanazawa, Shoko Watanabe et al. (15 authors)
JGH Open
Open Access
Published: Jul 2024
889 days after retraction
Hydroethanolic Extract of Lepidium apetalum Willdenow Alleviates Dextran Sulfate Sodium-Induced Colitis by Enhancing Intestinal Barrier Integrity and Inhibiting Oxidative Stress and Inflammasome Activation
Kwang-Youn Kim, Yun‐Mi Kang, Ami Lee et al. (6 authors)
Antioxidants
Open Access
Published: Jun 2024
3 citations
3 citations
887 days after retraction
C-terminal Poly-histidine Tags Alter Escherichia coli Polyphosphate Kinase Activity and Susceptibility to Inhibition
Marvin Q. Bowlin, Avery D. Lieber, Abagail R. Long et al. (4 authors)
Journal of Molecular Biology
Published: Jun 2024
2 citations
2 citations
868 days after retraction
Aloe emodin promotes mucosal healing by modifying the differentiation fate of enteroendocrine cells via regulating cellular free fatty acid sensitivity
Weilian Bao, Jiaren Lyu, Guize Feng et al. (11 authors)
Acta Pharmaceutica Sinica B
Open Access
Published: May 2024
2 citations
2 citations
858 days after retraction
How the Western Diet Thwarts the Epigenetic Efforts of Gut Microbes in Ulcerative Colitis and Its Association with Colorectal Cancer
Avisek Majumder, Shabana Bano
Biomolecules
Open Access
Published: May 2024
5 citations
5 citations
856 days after retraction
MnO2 and roflumilast-loaded probiotic membrane vesicles mitigate experimental colitis by synergistically augmenting cAMP in macrophage
Chengjun Song, Jiamin Wu, Jinhui Wu et al. (4 authors)
Journal of Nanobiotechnology
Open Access
Published: May 2024
5 citations
5 citations
855 days after retraction
Current Management of Acute Severe Ulcerative Colitis: New Insights on the Surgical Approaches
Sara Lauricella, Francesco Brucchi, Federica Cavalcoli et al. (9 authors)
Journal of Personalized Medicine
Open Access
Published: May 2024
2 citations
2 citations
855 days after retraction
Vaccine Acceptance in Patients with Inflammatory Bowel Disease: Lessons Learned from the COVID-19 Pandemic
Giada Mastrangeli, Filippo Vernia, Stefano Necozione et al. (8 authors)
Vaccines
Open Access
Published: May 2024
2 citations
2 citations
845 days after retraction
(-)-Fenchone Prevents Cysteamine-Induced Duodenal Ulcers and Accelerates Healing Promoting Re-Epithelialization of Gastric Ulcers in Rats via Antioxidant and Immunomodulatory Mechanisms
Maria Elaine Cristina Araruna, Edvaldo Balbino Alves Júnior, Catarina Alves de Lima Serafim et al. (12 authors)
Pharmaceuticals
Open Access
Published: May 2024
5 citations
5 citations
842 days after retraction
Histologic Disease Persists beyond Mucosal Healing and Could Predict Reactivation in Ulcerative Colitis
Lucrezia Laterza, A.C. Piscaglia, Stefano Bibbò et al. (17 authors)
Journal of Personalized Medicine
Open Access
Published: May 2024
2 citations
2 citations
837 days after retraction
Quick Stats
Total Citations:
1561
Years Since Retraction:
3.8 years
Open Access:
Yes
Last Checked:
Jul 24, 2025